{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:45:12Z","timestamp":1776775512827,"version":"3.51.2"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,7,14]],"date-time":"2011-07-14T00:00:00Z","timestamp":1310601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s10875-011-9566-y","type":"journal-article","created":{"date-parts":[[2011,7,13]],"date-time":"2011-07-13T16:08:17Z","timestamp":1310573297000},"page":"913-923","source":"Crossref","is-referenced-by-count":16,"title":["Endogenously Activated Interleukin-4 Differentiates Disease Progressors and Non-Progressors in Tuberculosis Susceptible Families: A 2-Year Biomarkers Follow-Up Study"],"prefix":"10.1007","volume":"31","author":[{"given":"Rabia","family":"Hussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najeeha","family":"Talat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambreen","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firdaus","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghaffar","family":"Dawood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,14]]},"reference":[{"issue":"6","key":"9566_CR1","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","volume":"178","author":"JL Flynn","year":"1993","unstructured":"Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An Essential role for Interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993;178(6):2249\u201354.","journal-title":"J Exp Med"},{"issue":"10","key":"9566_CR2","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI9166","volume":"105","author":"E Jouanguy","year":"2000","unstructured":"Jouanguy E, Dupuis S, Pallier A, Doffinger R, Fondaneche M-D, Fieschi C, et al. In a novel form of INF-\u03b3 receptor 1 deficiency, cell surface receptors fail to bind IFN-\u03b3. J Clin Invest. 2000;105(10):1429\u201336.","journal-title":"J Clin Invest"},{"key":"9566_CR3","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJM199612263352604","volume":"335","author":"E Jouanguy","year":"1996","unstructured":"Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, et al. Interferon gamma receptor deficiency in an infant with fatal Bacille Calmette-Guerin infection. N Engl J Med. 1996;335:1956\u201361.","journal-title":"N Engl J Med"},{"key":"9566_CR4","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/clinids\/24.5.982","volume":"24","author":"C Pierre-Audigier","year":"1997","unstructured":"Pierre-Audigier C, Jouanguy E, Lamhamedi S, Atlare F, Rauzier J, Vincent V. Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin Infect Dis. 1997;24:982\u20134.","journal-title":"Clin Infect Dis"},{"key":"9566_CR5","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0140-6736(03)13491-5","volume":"361","author":"M Rossouw","year":"2003","unstructured":"Rossouw M, Nel HJ, Cooke GS, van Helden PD, Hoal EG. Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet. 2003;361:1871\u20132.","journal-title":"Lancet"},{"issue":"4","key":"9566_CR6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1590\/S0100-879X2009000400002","volume":"42","author":"AC Leandro","year":"2009","unstructured":"Leandro AC, Rocha MA, Cardoso CS, Bonecini-Almeida MG. Genetic polymorphisms in vitamin D receptor, vitamin D-binding protein, Toll-like receptor 2, nitric oxide synthase 2, and interferon-gamma genes and its association with susceptibility to tuberculosis. Braz J Med Biol Res. 2009;42(4):312\u201322.","journal-title":"Braz J Med Biol Res"},{"issue":"12","key":"9566_CR7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00431-005-1689-9","volume":"164","author":"D Mansouri","year":"2005","unstructured":"Mansouri D, Adimi P, Mirsaeidi M, Mansouri N, Khalilzadeh S, Masjedi MR, et al. Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection. Eur J Pediatr. 2005;164(12):753\u20137.","journal-title":"Eur J Pediatr"},{"issue":"8","key":"9566_CR8","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1371\/journal.pgen.0020131","volume":"2","author":"A Chapgier","year":"2006","unstructured":"Chapgier A, Boisson-Dupuis S, Jouanguy E, Vogt G, Feinberg J, Prochnicka-Chalufour A, et al. Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease 4. PLoS Genet. 2006;2(8):e131.","journal-title":"PLoS Genet"},{"key":"9566_CR9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1164\/rccm.200601-088OC","volume":"174","author":"GS Cooke","year":"2006","unstructured":"Cooke GS, Campbell SJ, Sillah J, Gustafson P, Bah B, Sirugo G, et al. Polymorphism within the Interferon-\u03b3\/Receptor Complex is associated with Pulmonary Tuberculosis. Am J Respir Crit Care Med. 2006;174:339\u201343.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"9566_CR10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00439-008-0497-5","volume":"123","author":"AG Pacheco","year":"2008","unstructured":"Pacheco AG, Cardoso CC, Moraes MO. IFNG +874T\/A, IL10\u20131082G\/A and TNF -308G\/A polymorphisms in association with tuberculosis susceptibility: a meta-analysis study. Hum Genet. 2008;123(5):477\u201384.","journal-title":"Hum Genet"},{"issue":"1","key":"9566_CR11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clim.2010.09.005","volume":"138","author":"J Nemeth","year":"2011","unstructured":"Nemeth J, Winkler HM, Boeck L, Adegnika AA, Clement E, Mve TM, et al. Specific cytokine patterns of pulmonary tuberculosis in Central Africa. Clin Immunol. 2011;138(1):50\u20139.","journal-title":"Clin Immunol"},{"issue":"10","key":"9566_CR12","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1172\/JCI23215","volume":"114","author":"A O\u2019Garra","year":"2004","unstructured":"O\u2019Garra A, Vieira PL, Vieira P, Goldfeld AE. IL-10 producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest. 2004;114(10):1372\u20138.","journal-title":"J Clin Invest"},{"key":"9566_CR13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1574-695X.1997.tb01046.x","volume":"18","author":"D Dlugovitzky","year":"1997","unstructured":"Dlugovitzky D, Torres-Morales A, Rateni L, Farroni MA, Largacha C, Molteni O, et al. Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol Med Microbiol. 1997;18:203\u20137.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"9566_CR14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1365-2249.1999.00783.x","volume":"115","author":"A Verbon","year":"1999","unstructured":"Verbon A, Juffermans N, Deventer SJH, Speelman P, Deutekom HV, Poll TVD. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol. 1999;115:110\u20133.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"9566_CR15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-3083.2008.02217.x","volume":"69","author":"Z Hasan","year":"2009","unstructured":"Hasan Z, Jamil B, Khan J, Ali R, Khan MA, Nasir N, et al. Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity. Scand J Immunol. 2009;69(3):259\u201367.","journal-title":"Scand J Immunol"},{"issue":"2","key":"9566_CR16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1365-3083.1999.00492.x","volume":"49","author":"D Dlugovitzky","year":"1999","unstructured":"Dlugovitzky D, Bay ML, Rateni L, Urizar L, Rondelli CF, Largacha C, et al. In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement. Scand J Immunol. 1999;49(2):210\u20137.","journal-title":"Scand J Immunol"},{"key":"9566_CR17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-1759(02)00092-3","volume":"264","author":"R Hussain","year":"2002","unstructured":"Hussain R, Kaleem A, Shahid F, Dojki M, Jamil B, Mehmood H, et al. Cytokine profiles using whole blood assays can discriminate between tuberculosis patients and healthy endemic controls in BCG-vaccinated population. J Immunol Meth. 2002;264:95\u2013108.","journal-title":"J Immunol Meth"},{"issue":"8","key":"9566_CR18","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1128\/IAI.61.8.3482-3489.1993","volume":"61","author":"PF Barnes","year":"1993","unstructured":"Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, Modlin RL. Cytokine production at the site of disease in human tuberculosis. Infect Immun. 1993;61(8):3482\u20138.","journal-title":"Infect Immun"},{"key":"9566_CR19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/426139","volume":"40","author":"KA Wilkinson","year":"2005","unstructured":"Wilkinson KA, Wilkinson RJ, Pathan A, Ewer K, Prakash M, Klenerman P, et al. Ex Vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin Infect Dis. 2005;40:184\u20137.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"9566_CR20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1086\/318817","volume":"183","author":"CS Hirsch","year":"2001","unstructured":"Hirsch CS, Toossi Z, Johnson JL, Luzze H, Ntambi L, Peters P, et al. Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis. J Infect Dis. 2001;183(5):779\u201388.","journal-title":"J Infect Dis"},{"key":"9566_CR21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1086\/344903","volume":"36","author":"R Vankayalapati","year":"2003","unstructured":"Vankayalapati R, Wizel B, Weis SE, Klucar P, Shams H, Samten B, et al. Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis. Clin Infect Dis. 2003;36:24\u20138.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"9566_CR22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1128\/CDLI.8.6.1097-1103.2001","volume":"8","author":"J Jason","year":"2001","unstructured":"Jason J, Archibald LK, Nwanyanwu OC, Byrd MG, Kazembe PN, Dobbie H, et al. Comparison of serum and cell-specific cytokines in humans. Clin Diag Lab Immunol. 2001;8(6):1097\u2013103.","journal-title":"Clin Diag Lab Immunol"},{"key":"9566_CR23","volume-title":"Global Tuberculosis Control WHO report 2009: WHO\/HTM\/TB\/2009411","author":"WHO","year":"2009","unstructured":"WHO. Global Tuberculosis Control WHO report 2009: WHO\/HTM\/TB\/2009411. Geneva: WHO; 2009. Report No.: WHO report 2009 Country Profile."},{"key":"9566_CR24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2458-7-70","volume":"7","author":"S Akhtar","year":"2007","unstructured":"Akhtar S, White F, Hasan R, Rozi S, Younus M, Ahmed F, et al. Hyperendemic pulmonary tuberculosis in peri-urban areas of Karachi, Pakistan. BMC Public Health. 2007;7:70.","journal-title":"BMC Public Health"},{"issue":"3","key":"9566_CR25","first-page":"347","volume":"14","author":"P Tapaninen","year":"2010","unstructured":"Tapaninen P, Korhonen A, Pusa L, Seppala I, Tuuminen T. Effector memory T-cells dominate immune responses in tuberculosis treatment: antigen or bacteria persistence? Int J Tuberc Lung Dis. 2010;14(3):347\u201355.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"9566_CR26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cyto.2011.01.012","volume":"54","author":"N Talat","year":"2011","unstructured":"Talat N, Shahid F, Perry S, Dawood G, Hussain R. Th1\/Th2 Cytometric Bead Array can discriminate cytokine secretion from endogenously activated cells in pulmonary disease, recent and remote infection in tuberculosis. Cytokine. 2011;54(2):136\u201343.","journal-title":"Cytokine"},{"key":"9566_CR27","first-page":"395","volume-title":"Crofton and Douglas respiratory diseases. Clinical features of tuberculosis","author":"J Crofton","year":"1990","unstructured":"Crofton J. Crofton and Douglas respiratory diseases. Clinical features of tuberculosis. 4th ed. London: Blackwell; 1990. p. 395\u2013421.","edition":"4"},{"issue":"3","key":"9566_CR28","doi-asserted-by":"crossref","first-page":"e4778","DOI":"10.1371\/journal.pone.0004778","volume":"4","author":"A Ansari","year":"2009","unstructured":"Ansari A, Talat N, Jamil B, Hasan Z, Razzaki T, Dawood G, et al. Cytokine gene polymorphisms across tuberculosis clinical spectrum in Pakistani patients. PLoS One. 2009;4(3):e4778.","journal-title":"PLoS One"},{"issue":"6","key":"9566_CR29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-3083.2009.02250.x","volume":"69","author":"N Talat","year":"2009","unstructured":"Talat N, Shahid F, Dawood G, Hussain R. Dynamic changes in biomarker profiles associated with clinical and subclinical tuberculosis in a high transmission setting: a four-year follow-up study. Scand J Immunol. 2009;69(6):537\u201346.","journal-title":"Scand J Immunol"},{"key":"9566_CR30","first-page":"8","volume":"125","author":"G Comstock","year":"1982","unstructured":"Comstock G. Epidemiology of tuberculosis. Am J Respir Crit Care Med. 1982;125:8\u201315.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"9566_CR31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.it.2004.06.005","volume":"25","author":"GA Rook","year":"2004","unstructured":"Rook GA, Hernandez-Pando R, Dheda K, Teng SG. IL-4 in tuberculosis: implications for vaccine design. Trends Immunol. 2004;25(9):483\u20138.","journal-title":"Trends Immunol"},{"issue":"2","key":"9566_CR32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tube.2010.02.002","volume":"90","author":"M Moller","year":"2010","unstructured":"Moller M, Hoal EG. Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis (Edinb). 2010;90(2):71\u201383.","journal-title":"Tuberculosis (Edinb)"},{"issue":"12","key":"9566_CR33","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/rccm.200703-435OC","volume":"176","author":"EA Eijk van der","year":"2007","unstructured":"van der Eijk EA, van de Vosse E, Vandenbroucke JP, van Dissel JT. Heredity versus environment in tuberculosis in twins: the 1950s United Kingdom Prophit Survey Simonds and Comstock revisited. Am J Respir Crit Care Med. 2007;176(12):1281\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"9566_CR34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tube.2010.12.008","volume":"91","author":"A Mendez","year":"2011","unstructured":"Mendez A, Hernandez-Pando R, Contreras S, Aguilar D, Rook GA. CCL2, CCL18 and sIL-4R in renal, meningeal and pulmonary TB; a 2\u00a0year study of patients and contacts. Tuberculosis (Edinb). 2011;91(2):140\u20135.","journal-title":"Tuberculosis (Edinb)"},{"issue":"12","key":"9566_CR35","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/CVI.00289-07","volume":"14","author":"R Hussain","year":"2007","unstructured":"Hussain R, Talat N, Shahid F, Dawood G. Longitudinal tracking of cytokines after acute exposure to Tuberculosis: Association of Distinct Cytokine patterns with protection and disease development. Clin Vaccine Immunol. 2007;14(12):1578\u201386.","journal-title":"Clin Vaccine Immunol"},{"key":"9566_CR36","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/507427","volume":"194","author":"D Goletti","year":"2006","unstructured":"Goletti D, Butera O, Bizzoni F, Casetti R, Girardi E, Poccia F. Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J Infect Dis. 2006;194:984\u201392.","journal-title":"J Infect Dis"},{"issue":"2","key":"9566_CR37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/eji.201040668","volume":"41","author":"SH Kim","year":"2011","unstructured":"Kim SH, Lee CE. Counter-regulation mechanism of IL-4 and IFN-alpha signal transduction through cytosolic retention of the pY-STAT6:pY-STAT2:p48 complex. Eur J Immunol. 2011;41(2):461\u201372.","journal-title":"Eur J Immunol"},{"issue":"2","key":"9566_CR38","doi-asserted-by":"crossref","first-page":"998","DOI":"10.4049\/jimmunol.0903372","volume":"185","author":"SH Apte","year":"2010","unstructured":"Apte SH, Groves P, Olver S, Baz A, Doolan DL, Kelso A, et al. IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response. J Immunol. 2010;185(2):998\u20131004.","journal-title":"J Immunol"},{"issue":"2","key":"9566_CR39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jlb.55.2.227","volume":"55","author":"C Bogdan","year":"1994","unstructured":"Bogdan C, Vodovotz Y, Paik J, Xie QW, Nathan C. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J Leukoc Biol. 1994;55(2):227\u201333.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"9566_CR40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nm864","volume":"9","author":"SR Krutzik","year":"2003","unstructured":"Krutzik SR, Ochoa MT, Sieling PA, Uematsu S, Ng YW, Legaspi A, et al. Activation and regulation of Toll like receptors 2 and 1 in human leprosy. Nature Med. 2003;9(5):525\u201332.","journal-title":"Nature Med"},{"issue":"1","key":"9566_CR41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3(1):23\u201335.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"9566_CR42","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2567.2004.01922.x","volume":"112","author":"HA Fletcher","year":"2004","unstructured":"Fletcher HA, Owiafe P, Jeffries D, Hill P, Rook GA, Zumla A, et al. Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation. Immunology. 2004;112(4):669\u201373.","journal-title":"Immunology"},{"issue":"11","key":"9566_CR43","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.4049\/jimmunol.172.11.6938","volume":"172","author":"A Demissie","year":"2004","unstructured":"Demissie A, Abebe M, Aseffa A, Rook G, Fletcher H, Zumla A, et al. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol. 2004;172(11):6938\u201343.","journal-title":"J Immunol"},{"issue":"3","key":"9566_CR44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2567.2010.03393.x","volume":"132","author":"IG Luzina","year":"2011","unstructured":"Luzina IG, Lockatell V, Todd NW, Keegan AD, Hasday JD, Atamas SP. Splice isoforms of human interleukin-4 are functionally active in mice in vivo. Immunology. 2011;132(3):385\u201393.","journal-title":"Immunology"},{"issue":"4","key":"9566_CR45","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1164\/rccm.200502-278OC","volume":"172","author":"K Dheda","year":"2005","unstructured":"Dheda K, Chang JS, Breen RA, Kim LU, Haddock JA, Huggett JF, et al. In vivo and in vitro studies of a novel cytokine, interleukin 4delta2, in pulmonary tuberculosis. Am J Respir Crit Care Med. 2005;172(4):501\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"9566_CR46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1172\/JCI200522433","volume":"115","author":"A Doganci","year":"2005","unstructured":"Doganci A, Eigenbrod T, Krug N, De Sanctis GT, Hausding M, Erpenbeck VJ, et al. The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. J Clin Invest. 2005;115(2):313\u201325.","journal-title":"J Clin Invest"},{"issue":"8","key":"9566_CR47","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1469-0691.2009.03104.x","volume":"16","author":"R Biselli","year":"2010","unstructured":"Biselli R, Mariotti S, Sargentini V, Sauzullo I, Lastilla M, Mengoni F, et al. Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls. Clin Microbiol Infect. 2010;16(8):1282\u20134.","journal-title":"Clin Microbiol Infect"},{"key":"9566_CR48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2334-9-99","volume":"9","author":"V Sargentini","year":"2009","unstructured":"Sargentini V, Mariotti S, Carrara S, Gagliardi MC, Teloni R, Goletti D, et al. Cytometric detection of antigen-specific IFN-gamma\/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect Dis. 2009;9:99.","journal-title":"BMC Infect Dis"},{"key":"9566_CR49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2249.2006.03027.x","volume":"144","author":"R Ribeiro-Rodrigues","year":"2006","unstructured":"Ribeiro-Rodrigues R. Resende Co T, Rojas R, Toossi Z, Dietze R, Boom WH, et al. A role of CD4+CD25+ T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol. 2006;144:25\u201334.","journal-title":"Clin Exp Immunol"},{"key":"9566_CR50","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.trstmh.2004.01.007","volume":"98","author":"AM Elliot","year":"2004","unstructured":"Elliot AM, Hodsdon WS, Kyosiimire J, Quigley MA, Nakiyingi JS, Namujju PB, et al. Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study. Trans Roy SocTrop Med & Hyg. 2004;98:660\u201370.","journal-title":"Trans Roy SocTrop Med & Hyg"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-011-9566-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-011-9566-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-011-9566-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T08:46:32Z","timestamp":1592729192000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-011-9566-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,14]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["9566"],"URL":"https:\/\/doi.org\/10.1007\/s10875-011-9566-y","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,14]]}}}